Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 6:18 pm Purchase |
2023-12-31 | 13G | Intuitive Machines, Inc. LUNR |
Citadel Advisors LLC | 843,505 3.900% |
843,505 (New Position) |
Filing History |
| 2024-02-14 6:18 pm Sale |
2023-12-31 | 13G | Appreciate Holdings, Inc. SFRT |
Citadel Advisors LLC | 965,611 5.400% |
-154,481 (-13.79%) |
Filing History |
| 2024-02-14 6:18 pm Purchase |
2023-12-31 | 13G | Acelyrin, Inc. SLRN |
Citadel Advisors LLC | 6,649,442 6.800% |
685,642 (+11.50%) |
Filing History |
| 2024-02-14 6:18 pm Sale |
2023-12-31 | 13G | Benitec Biopharma Inc. BNTC |
Citadel Advisors LLC | 95,356 3.600% |
-84,674 (-47.03%) |
Filing History |
| 2024-02-14 6:18 pm Sale |
2023-12-31 | 13G | Clene Inc. CLNN |
Citadel Advisors LLC | 302,516 4.500% |
-78,703 (-20.65%) |
Filing History |
| 2024-02-14 6:18 pm Sale |
2023-12-31 | 13G | Applied Optoelectronics, Inc. AAOI |
Citadel Advisors LLC | 506,340 1.200% |
-1,324,593 (-72.35%) |
Filing History |
| 2024-02-14 4:58 pm Sale |
2023-12-31 | 13G | Aerovate Therapeutics, Inc. AVTE |
Citadel Advisors LLC | 94 0.000% |
-44,534 (-99.79%) |
Filing History |
| 2024-02-14 4:58 pm Purchase |
2023-12-31 | 13G | Dianthus Therapeutics, Inc. DNTH |
Citadel Advisors LLC | 2,880 0.000% |
2,880 (New Position) |
Filing History |
| 2024-02-14 4:58 pm Sale |
2023-12-31 | 13G | FIGS, Inc. FIGS |
Citadel Advisors LLC | 611,989 0.400% |
-8,605,659 (-93.36%) |
Filing History |
| 2024-02-14 4:58 pm Purchase |
2023-12-31 | 13G | AlTi Global, Inc. ALTI |
Citadel Advisors LLC | 441 0.000% |
441 (New Position) |
Filing History |
| 2024-02-14 4:58 pm Purchase |
2023-12-31 | 13G | Inflection Point Acquisition Corp. II IPXX |
Citadel Advisors LLC | 3,666 0.000% |
3,666 (New Position) |
Filing History |
| 2024-02-14 4:58 pm Purchase |
2023-12-31 | 13G | Alchemy Investments Acquisition Corp 1 ALCY |
Citadel Advisors LLC | 1,985 0.000% |
1,985 (New Position) |
Filing History |
| 2024-02-14 4:58 pm Sale |
2023-12-31 | 13G | 2seventy bio, Inc. TSVT |
Citadel Advisors LLC | 146,401 0.300% |
-2,445,205 (-94.35%) |
Filing History |
| 2024-02-14 4:58 pm Sale |
2023-12-31 | 13G | Arhaus, Inc. ARHS |
Citadel Advisors LLC | 450,504 0.900% |
-2,437,203 (-84.40%) |
Filing History |
| 2024-02-14 4:58 pm Sale |
2023-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
Citadel Advisors LLC | 1,236,850 2.400% |
-1,022,891 (-45.27%) |
Filing History |
| 2024-02-14 4:58 pm Sale |
2023-12-31 | 13G | Semper Paratus Acquisition Corporation LGST |
Citadel Advisors LLC | 5,846 0.000% |
-927,608 (-99.37%) |
Filing History |
| 2024-02-14 4:58 pm Purchase |
2023-12-31 | 13G | Enliven Therapeutics, Inc. ELVN |
Citadel Advisors LLC | 2,394,448 5.800% |
95,692 (+4.16%) |
Filing History |
| 2024-02-14 4:58 pm Sale |
2023-12-31 | 13G | Annexon, Inc. ANNX |
Citadel Advisors LLC | 1,069,087 1.400% |
-1,431,220 (-57.24%) |
Filing History |
| 2024-02-14 4:58 pm Sale |
2023-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
Citadel Advisors LLC | 390,512 0.700% |
-2,292,302 (-85.44%) |
Filing History |
| 2024-02-14 4:58 pm Sale |
2023-12-31 | 13G | Design Therapeutics, Inc. DSGN |
Citadel Advisors LLC | 1,834,854 3.300% |
-1,036,413 (-36.10%) |
Filing History |